Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong · Delayed Price · Currency is HKD 30.46
+0.84 (2.84%)
Sep 30, 2025, 4:08 PM HKT
HKG:1877 Market Cap
HKG:1877 has a market cap or net worth of 42.62 billion as of September 30, 2025. Its market cap has increased by 85.03% in one year.
Market Cap
42.62B
Enterprise Value
42.63B
Revenue
2.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
30.46
Market Cap Chart
Since December 24, 2018, HKG:1877's market cap has increased from 18.06B to 42.62B, an increase of 136.02%. That is a compound annual growth rate of 13.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 42.62B | 71.83% |
| Dec 31, 2024 | 24.81B | -37.28% |
| Dec 29, 2023 | 39.55B | -38.85% |
| Dec 30, 2022 | 64.67B | -7.04% |
| Dec 31, 2021 | 69.57B | -9.43% |
| Dec 31, 2020 | 76.81B | 266.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 279.26B |
| Hansoh Pharmaceutical Group Company | 214.55B |
| JD Health International | 206.50B |
| WuXi Biologics | 160.93B |
| Innovent Biologics | 160.31B |
| Sino Biopharmaceutical | 142.12B |
| Akeso | 124.26B |
| Sichuan Kelun-Biotech Biopharmaceutical | 113.38B |